JPWO2021105964A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021105964A5 JPWO2021105964A5 JP2022527775A JP2022527775A JPWO2021105964A5 JP WO2021105964 A5 JPWO2021105964 A5 JP WO2021105964A5 JP 2022527775 A JP2022527775 A JP 2022527775A JP 2022527775 A JP2022527775 A JP 2022527775A JP WO2021105964 A5 JPWO2021105964 A5 JP WO2021105964A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- women
- hmo
- breast milk
- later date
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201901402 | 2019-11-29 | ||
DKPA201901402 | 2019-11-29 | ||
PCT/IB2020/061258 WO2021105964A1 (en) | 2019-11-29 | 2020-11-30 | Mixture of hmos for improving the microbiota of pregnant women |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023503401A JP2023503401A (ja) | 2023-01-30 |
JPWO2021105964A5 true JPWO2021105964A5 (de) | 2023-11-08 |
Family
ID=76130109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022527775A Pending JP2023503401A (ja) | 2019-11-29 | 2020-11-30 | 妊婦の細菌叢を改善するためのhmoの混合物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230012011A1 (de) |
EP (1) | EP4065128A4 (de) |
JP (1) | JP2023503401A (de) |
KR (1) | KR20220107011A (de) |
CN (1) | CN114761024A (de) |
BR (1) | BR112022010061A2 (de) |
WO (1) | WO2021105964A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115918916A (zh) * | 2022-11-29 | 2023-04-07 | 黑龙江飞鹤乳业有限公司 | 含母乳低聚糖和乳铁蛋白的营养组合物、食品及用途 |
CN115843880A (zh) * | 2022-11-29 | 2023-03-28 | 黑龙江飞鹤乳业有限公司 | 含母乳低聚糖和骨桥蛋白的营养组合物、食品及用途 |
CN115868632A (zh) * | 2022-11-29 | 2023-03-31 | 黑龙江飞鹤乳业有限公司 | 含母乳低聚糖和益生菌的营养组合物、食品及用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2645472C (en) * | 2006-03-10 | 2015-09-15 | N.V. Nutricia | Use of non-digestable saccharides for giving an infant the best start after birth |
WO2012092160A2 (en) * | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Human milk oligosaccharides to promote growth of beneficial bacteria |
CN107106582A (zh) * | 2014-09-15 | 2017-08-29 | N·V·努特里奇亚 | 降低后代焦虑 |
MX2018007124A (es) * | 2015-12-15 | 2018-09-07 | Nestec Sa | Mezcla de hmo. |
CN110573030A (zh) * | 2017-05-24 | 2019-12-13 | 雀巢产品有限公司 | 用于增强注意力和/或降低冲动的营养组合物 |
EP3720446A4 (de) * | 2017-12-05 | 2021-09-15 | Glycom A/S | Menschliche milcholigosaccharide zur behandlung von migräne |
-
2020
- 2020-11-30 US US17/780,390 patent/US20230012011A1/en active Pending
- 2020-11-30 CN CN202080082094.5A patent/CN114761024A/zh active Pending
- 2020-11-30 EP EP20894211.0A patent/EP4065128A4/de active Pending
- 2020-11-30 KR KR1020227021603A patent/KR20220107011A/ko active Search and Examination
- 2020-11-30 BR BR112022010061A patent/BR112022010061A2/pt unknown
- 2020-11-30 WO PCT/IB2020/061258 patent/WO2021105964A1/en unknown
- 2020-11-30 JP JP2022527775A patent/JP2023503401A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guclu et al. | Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature | |
Patel et al. | Association of ABO and Rh incompatibility with neonatal hyperbilirubinaemia | |
Mori et al. | Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle‐aged Japanese women | |
JPWO2021105964A5 (de) | ||
Cherry et al. | Primary hyperparathyroidism, hypercalcemic crisis and subsequent seizures occurring during pregnancy: a case report | |
Baig et al. | Studies on Zn, Cu, Mg, Ca and phosphorus in maternal and cord blood | |
Schwarzer et al. | Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine | |
Bass et al. | Trisomy 18 mosaicism: clues to the diagnosis | |
Conde et al. | CNS siderosis and dandy-walker variant after neonatal alloimmune thrombocytopenia | |
Maurovich-Horvat1ABCDEF et al. | Assessment of pregnancy outcomes in Czech and Slovak women with narcolepsy | |
EP4285378A1 (de) | Verfahren zur bestimmung der personalisierten dha-ergänzung | |
Merlob et al. | Psychotropic drugs | |
CN101518615B (zh) | 一种治疗妊娠反应的中药组合物 | |
Tu et al. | Serotonin metabolism in normal and abnormal infants during the perinatal period | |
CN108310123A (zh) | 一种用于预防和/或治疗高尿酸血症的药物组合物及其制备方法和用途 | |
Evans et al. | Neonatal serotonin toxicity | |
Doig et al. | Megaloblastic anaemia during combined phensuximide and phenobarbitone therapy | |
JP2012530046A (ja) | 出生児の出生体重の低下リスクを防ぐ妊婦用の乳由来組成物 | |
Lundberg | Hereditary Polyneuropathy, Oligophrenia, Premature Menopause and Acromicria: A New Syndrome | |
Monroe | Menstruation, menopause, and HIV | |
Jatana | 2 Nutrition in Women Health | |
Derouiche et al. | Study of Socioclinical Risk Factors for Breast Milk Deficiency in Women During Lactation | |
CN112807392A (zh) | 一种针对糖尿病前期人群的中药组合物及制备方法 | |
Sachar et al. | Primary biliary cirrhosis | |
Hoover et al. | Drug-Nutrient Interaction Considerations in Pregnancy and Lactation |